To further delineate the role and explore the translational relevance of our findings, we examined if GPR15 agonism by GPR15L administration would elicit an anti-tumor effect by influencing immune cell phenotypes and their functionality in the MC38-murine CRC model. The gene discussed is GPR15; the disease is colorectal carcinoma.